At the ARU Core Laboratory experts in the field score all images and give an independent assessment. This minimises variability, increases data quality and enhances the ability to detect treatment effects.
We assist sponsors in the use of endpoints that depend on the results of imaging tests both in clinical trials of therapeutic drugs and medical devices.
We provide guidance on the imaging standards that we regard as important when imaging is used to assess a primary endpoint, or an endpoint component, in a clinical trial.
We help ensure that imaging data is obtained in a manner that complies with a trial’s protocol, that the quality of imaging data is maintained within and among clinical sites, and that there is a verifiable record of the imaging process.
Imaging data is used for assessment of structures or pathology and diagnostic or therapeutic patient management. It’s used in the evaluation of medical devices and in drug development and is often a component of the primary or secondary endpoints. Imaging may assist in the assessment of efficacy and safety as well as patient eligibility.
For more information or to talk about your needs, please contact firstname.lastname@example.org.